{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:29:23Z","timestamp":1782484163467,"version":"3.54.5"},"reference-count":49,"publisher":"Japan Atherosclerosis Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2022,1,1]]},"DOI":"10.5551\/jat.59881","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T22:21:35Z","timestamp":1610144495000},"page":"50-68","source":"Crossref","is-referenced-by-count":4,"title":["High-Density Lipoprotein Cholesterol and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Statins: An Observation from the REAL-CAD Study"],"prefix":"10.5551","volume":"29","author":[{"given":"Kazunori","family":"Omote","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Yokota","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Graduate School of Medicine, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Sakuma","sequence":"additional","affiliation":[{"name":"Caress Sapporo Hokko Memorial Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Shiga University of Medical Science Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiwamu","family":"Kamiya","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fujita Health University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Hibi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yokohama City University Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Hiro","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyoshi","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Showa University Fujigaoka Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Hokimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kumamoto University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Department of Integrated Science and Technology for Sustainable Society, Chuo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ohtsu","sequence":"additional","affiliation":[{"name":"National Center for Global Health and Medicine, Center for Clinical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisao","family":"Ogawa","sequence":"additional","affiliation":[{"name":"National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Daida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Iimuro","sequence":"additional","affiliation":[{"name":"Teikyo Academic Research Center, Teikyo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Shimokawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Saito","sequence":"additional","affiliation":[{"name":"Chiba University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masunori","family":"Matsuzaki","sequence":"additional","affiliation":[{"name":"St. Hill Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryozo","family":"Nagai","sequence":"additional","affiliation":[{"name":"Jichi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Anzai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Baigent, C, Keech, A, Kearney, PM, Blackwell, L, Buck, G, Pollicino, C, Kirby, A, Sourjina, T, Peto, R, Collins, R and Simes, R: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet, 2005; 366: 1267-1278","DOI":"10.1016\/S0140-6736(05)67394-1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Grundy, SM: HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N Engl J Med, 1988; 319: 24-33","DOI":"10.1056\/NEJM198807073190105"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Grundy, SM, Stone, NJ, Bailey, AL, Beam, C, Birtcher, KK, Blumenthal, RS, Braun, LT, de Ferranti, S, Faiella-Tommasino, J, Forman, DE, Goldberg, R, Heidenreich, PA, Hlatky, MA, Jones, DW, Lloyd-Jones, D, Lopez-Pajares, N, Ndumele, CE, Orringer, CE, Peralta, CA, Saseen, JJ, Smith, SC, Jr., Sperling, L, Virani, SS and Yeboah, J: 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 2019; 139: e1082-e1143","DOI":"10.1161\/CIR.0000000000000624"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Catapano, AL, Graham, I, De Backer, G, Wiklund, O, Chapman, MJ, Drexel, H, Hoes, AW, Jennings, CS, Landmesser, U, Pedersen, TR, Reiner, Z, Riccardi, G, Taskinen, MR, Tokgozoglu, L, Verschuren, WMM, Vlachopoulos, C, Wood, DA, Zamorano, JL and Cooney, MT: 2016 ESC\/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J, 2016; 37: 2999-3058","DOI":"10.1093\/eurheartj\/ehw272"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Rader, DJ and Hovingh, GK: HDL and cardiovascular disease. Lancet, 2014; 384: 618-625","DOI":"10.1016\/S0140-6736(14)61217-4"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Gordon, T, Castelli, WP, Hjortland, MC, Kannel, WB and Dawber, TR: High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med, 1977; 62: 707-714","DOI":"10.1016\/0002-9343(77)90874-9"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Castelli, WP, Garrison, RJ, Wilson, PW, Abbott, RD, Kalousdian, S and Kannel, WB: Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA, 1986; 256: 2835-2838","DOI":"10.1001\/jama.256.20.2835"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Gordon, DJ, Probstfield, JL, Garrison, RJ, Neaton, JD, Castelli, WP, Knoke, JD, Jacobs, DR, Jr., Bangdiwala, S and Tyroler, HA: High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation, 1989; 79: 8-15","DOI":"10.1161\/01.CIR.79.1.8"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Frost, PH, Davis, BR, Burlando, AJ, Curb, JD, Guthrie, GP, Jr., Isaacsohn, JL, Wassertheil-Smoller, S, Wilson, AC and Stamler, J: Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP). Circulation, 1996; 94: 2381-2388","DOI":"10.1161\/01.CIR.94.10.2381"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) deGoma, EM, Leeper, NJ and Heidenreich, PA: Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol. J Am Coll Cardiol, 2008; 51: 49-55","DOI":"10.1016\/j.jacc.2007.07.086"},{"key":"11","unstructured":"11) Di Angelantonio, E, Gao, P, Pennells, L, Kaptoge, S, Caslake, M, Thompson, A, Butterworth, AS, Sarwar, N, Wormser, D, Saleheen, D, Ballantyne, CM, Psaty, BM, Sundstrom, J, Ridker, PM, Nagel, D, Gillum, RF, Ford, I, Ducimetiere, P, Kiechl, S, Koenig, W, Dullaart, RP, Assmann, G, D\u2019Agostino, RB, Sr., Dagenais, GR, Cooper, JA, Kromhout, D, Onat, A, Tipping, RW, Gomez-de-la-Camara, A, Rosengren, A, Sutherland, SE, Gallacher, J, Fowkes, FG, Casiglia, E, Hofman, A, Salomaa, V, Barrett-Connor, E, Clarke, R, Brunner, E, Jukema, JW, Simons, LA, Sandhu, M, Wareham, NJ, Khaw, KT, Kauhanen, J, Salonen, JT, Howard, WJ, Nordestgaard, BG, Wood, AM, Thompson, SG, Boekholdt, SM, Sattar, N, Packard, C, Gudnason, V and Danesh, J: Lipid-related markers and cardiovascular disease prediction. JAMA, 2012; 307: 2499-2506"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Madsen, CM, Varbo, A and Nordestgaard, BG: Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J, 2017; 38: 2478-2486","DOI":"10.1093\/eurheartj\/ehx163"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Ko, DT, Alter, DA, Guo, H, Koh, M, Lau, G, Austin, PC, Booth, GL, Hogg, W, Jackevicius, CA, Lee, DS, Wijeysundera, HC, Wilkins, JT and Tu, JV: High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions: The CANHEART Study. J Am Coll Cardiol, 2016; 68: 2073-2083","DOI":"10.1016\/j.jacc.2016.08.038"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Hirata, A, Sugiyama, D, Watanabe, M, Tamakoshi, A, Iso, H, Kotani, K, Kiyama, M, Yamada, M, Ishikawa, S, Murakami, Y, Miura, K, Ueshima, H and Okamura, T: Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH-JAPAN study. J Clin Lipidol, 2018; 12: 674-684.e675","DOI":"10.1016\/j.jacl.2018.01.014"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Izuhara, M, Ono, K, Shiomi, H, Morimoto, T, Furukawa, Y, Nakagawa, Y, Shizuta, S, Tada, T, Tazaki, J, Horie, T, Kuwabara, Y, Baba, O, Nishino, T, Kita, T and Kimura, T: High-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after percutaneous coronary intervention: a report from the CREDO-Kyoto registry cohort-2. Atherosclerosis, 2015; 242: 632-638","DOI":"10.1016\/j.atherosclerosis.2015.05.010"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Hirata, T, Sugiyama, D, Nagasawa, SY, Murakami, Y, Saitoh, S, Okayama, A, Iso, H, Irie, F, Sairenchi, T, Miyamoto, Y, Yamada, M, Ishikawa, S, Miura, K, Ueshima, H and Okamura, T: A pooled analysis of the association of isolated low levels of high-density lipoprotein cholesterol with cardiovascular mortality in Japan. Eur J Epidemiol, 2017; 32: 547-557","DOI":"10.1007\/s10654-016-0203-1"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Watanabe, J, Kakehi, E, Kotani, K, Kayaba, K, Nakamura, Y and Ishikawa, S: Isolated low levels of high-density lipoprotein cholesterol and stroke incidence: JMS Cohort Study. J Clin Lab Anal, 2020; 34: e23087","DOI":"10.1002\/jcla.23087"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Barter, P, Gotto, AM, LaRosa, JC, Maroni, J, Szarek, M, Grundy, SM, Kastelein, JJ, Bittner, V and Fruchart, JC: HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med, 2007; 357: 1301-1310","DOI":"10.1056\/NEJMoa064278"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Nakazawa, M, Arashi, H, Yamaguchi, J, Ogawa, H and Hagiwara, N: Lower levels of high-density lipoprotein cholesterol are associated with increased cardiovascular events in patients with acute coronary syndrome. Atherosclerosis, 2020; 303: 21-28","DOI":"10.1016\/j.atherosclerosis.2020.05.005"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Taguchi, I, Iimuro, S, Iwata, H, Takashima, H, Abe, M, Amiya, E, Ogawa, T, Ozaki, Y, Sakuma, I, Nakagawa, Y, Hibi, K, Hiro, T, Fukumoto, Y, Hokimoto, S, Miyauchi, K, Yamazaki, T, Ito, H, Otsuji, Y, Kimura, K, Takahashi, J, Hirayama, A, Yokoi, H, Kitagawa, K, Urabe, T, Okada, Y, Terayama, Y, Toyoda, K, Nagao, T, Matsumoto, M, Ohashi, Y, Kaneko, T, Fujita, R, Ohtsu, H, Ogawa, H, Daida, H, Shimokawa, H, Saito, Y, Kimura, T, Inoue, T, Matsuzaki, M and Nagai, R: High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial. Circulation, 2018; 137: 1997-2009","DOI":"10.1161\/CIRCULATIONAHA.117.032615"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Austen, WG, Edwards, JE, Frye, RL, Gensini, GG, Gott, VL, Griffith, LS, McGoon, DC, Murphy, ML and Roe, BB: A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation, 1975; 51: 5-40","DOI":"10.1161\/01.CIR.51.4.5"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Miyauchi, K, Kimura, T, Shimokawa, H, Daida, H, Iimuro, S, Iwata, H, Ozaki, Y, Sakuma, I, Nakagawa, Y, Hibi, K, Hiro, T, Fukumoto, Y, Hokimoto, S, Ohashi, Y, Ohtsu, H, Saito, Y, Matsuzaki, M and Nagai, R: Rationale and Design of Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy with Pitavastatin in Coronary Artery Disease (REAL-CAD) Trial. Int Heart J, 2018; 59: 315-320","DOI":"10.1536\/ihj.17-557"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Makuch, RW: Adjusted survival curve estimation using covariates. J Chronic Dis, 1982; 35: 437-443","DOI":"10.1016\/0021-9681(82)90058-3"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Rubin, EM, Krauss, RM, Spangler, EA, Verstuyft, JG and Clift, SM: Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature, 1991; 353: 265-267","DOI":"10.1038\/353265a0"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Soria-Florido, MT, Schr\u00f6der, H, Grau, M, Fit\u00f3, M and Lassale, C: High density lipoprotein functionality and cardiovascular events and mortality: A systematic review and meta-analysis. Atherosclerosis, 2020; 302: 36-42","DOI":"10.1016\/j.atherosclerosis.2020.04.015"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Krieger, M: Charting the fate of the \u201cgood cholesterol\u201d: identification and characterization of the high-density lipoprotein receptor SR-BI. Annu Rev Biochem, 1999; 68: 523-558","DOI":"10.1146\/annurev.biochem.68.1.523"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Assmann, G and Nofer, JR: Atheroprotective effects of high-density lipoproteins. Annu Rev Med, 2003; 54: 321-341","DOI":"10.1146\/annurev.med.54.101601.152409"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Barter, PJ, Nicholls, S, Rye, KA, Anantharamaiah, GM, Navab, M and Fogelman, AM: Antiinflammatory properties of HDL. Circ Res, 2004; 95: 764-772","DOI":"10.1161\/01.RES.0000146094.59640.13"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Mineo, C, Deguchi, H, Griffin, JH and Shaul, PW: Endothelial and antithrombotic actions of HDL. Circ Res, 2006; 98: 1352-1364","DOI":"10.1161\/01.RES.0000225982.01988.93"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Hafiane, A and Genest, J: HDL, Atherosclerosis, and Emerging Therapies. Cholesterol, 2013; 2013: 891403","DOI":"10.1155\/2013\/891403"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Assmann, G and Gotto, AM, Jr.: HDL cholesterol and protective factors in atherosclerosis. Circulation, 2004; 109: Iii8-14","DOI":"10.1161\/01.CIR.0000131512.50667.46"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Pirillo, A and Catapano, AL: Pitavastatin and HDL: Effects on plasma levels and function(s). Atheroscler Suppl, 2017; 27: e1-e9","DOI":"10.1016\/j.atherosclerosissup.2017.05.001"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Bandeali, S and Farmer, J: High-density lipoprotein and atherosclerosis: the role of antioxidant activity. Curr Atheroscler Rep, 2012; 14: 101-107","DOI":"10.1007\/s11883-012-0235-2"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Barter, PJ, Caulfield, M, Eriksson, M, Grundy, SM, Kastelein, JJ, Komajda, M, Lopez-Sendon, J, Mosca, L, Tardif, JC, Waters, DD, Shear, CL, Revkin, JH, Buhr, KA, Fisher, MR, Tall, AR and Brewer, B: Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med, 2007; 357: 2109-2122","DOI":"10.1056\/NEJMoa0706628"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Landray, MJ, Haynes, R, Hopewell, JC, Parish, S, Aung, T, Tomson, J, Wallendszus, K, Craig, M, Jiang, L, Collins, R and Armitage, J: Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med, 2014; 371: 203-212","DOI":"10.1056\/NEJMoa1300955"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Boden, WE, Probstfield, JL, Anderson, T, Chaitman, BR, Desvignes-Nickens, P, Koprowicz, K, McBride, R, Teo, K and Weintraub, W: Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med, 2011; 365: 2255-2267","DOI":"10.1056\/NEJMoa1107579"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Ginsberg, HN, Elam, MB, Lovato, LC, Crouse, JR, 3rd, Leiter, LA, Linz, P, Friedewald, WT, Buse, JB, Gerstein, HC, Probstfield, J, Grimm, RH, Ismail-Beigi, F, Bigger, JT, Goff, DC, Jr., Cushman, WC, Simons-Morton, DG and Byington, RP: Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med, 2010; 362: 1563-1574","DOI":"10.1056\/NEJMoa1001282"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Johannsen, TH, Frikke-Schmidt, R, Schou, J, Nordestgaard, BG and Tybjaerg-Hansen, A: Genetic inhibition of CETP, ischemic vascular disease and mortality, and possible adverse effects. J Am Coll Cardiol, 2012; 60: 2041-2048","DOI":"10.1016\/j.jacc.2012.07.045"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Khera, AV, Cuchel, M, de la Llera-Moya, M, Rodrigues, A, Burke, MF, Jafri, K, French, BC, Phillips, JA, Mucksavage, ML, Wilensky, RL, Mohler, ER, Rothblat, GH and Rader, DJ: Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med, 2011; 364: 127-135","DOI":"10.1056\/NEJMoa1001689"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Angeloni, E, Paneni, F, Landmesser, U, Benedetto, U, Melina, G, Luscher, TF, Volpe, M, Sinatra, R and Cosentino, F: Lack of protective role of HDL-C in patients with coronary artery disease undergoing elective coronary artery bypass grafting. Eur Heart J, 2013; 34: 3557-3562","DOI":"10.1093\/eurheartj\/eht163"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Silbernagel, G, Schottker, B, Appelbaum, S, Scharnagl, H, Kleber, ME, Grammer, TB, Ritsch, A, Mons, U, Holleczek, B, Goliasch, G, Niessner, A, Boehm, BO, Schnabel, RB, Brenner, H, Blankenberg, S, Landmesser, U and Marz, W: High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality. Eur Heart J, 2013; 34: 3563-3571","DOI":"10.1093\/eurheartj\/eht343"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Ridker, PM, Genest, J, Boekholdt, SM, Libby, P, Gotto, AM, Nordestgaard, BG, Mora, S, MacFadyen, JG, Glynn, RJ and Kastelein, JJ: HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial. Lancet, 2010; 376: 333-339","DOI":"10.1016\/S0140-6736(10)60713-1"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Mu\u00f1oz-Hernandez, L, Ortiz-Bautista, RJ, Brito-C\u00f3rdova, G, Lozano-Arvizu, F, Saucedo, S, P\u00e9rez-M\u00e9ndez, O, Zentella-Dehesa, A, Dauteuille, C, Lhomme, M, Lesnik, P, Chapman, MJ, Kontush, A and Aguilar Salinas, CA: Cholesterol efflux capacity of large, small and total HDL particles is unaltered by atorvastatin in patients with type 2 diabetes. Atherosclerosis, 2018; 277: 72-79","DOI":"10.1016\/j.atherosclerosis.2018.08.027"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Choi, JY, Choi, CU, Hwang, SY, Choi, BG, Jang, WY, Kim, DY, Kim, W, Park, EJ, Lee, S, Na, JO, Kim, JW, Kim, EJ, Rha, SW, Park, CG, Seo, HS, Chae, SC, Kim, YJ, Cho, MC, Kim, CJ, Kim, HS and Jeong, MH: Effect of Pitavastatin Compared with Atorvastatin andRosuvastatin on New-Onset Diabetes Mellitus in PatientsWith Acute Myocardial Infarction. Am J Cardiol, 2018; 122: 922-928","DOI":"10.1016\/j.amjcard.2018.06.017"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Sakabe, K, Fukuda, N, Fukuda, Y, Wakayama, K, Nada, T, Morishita, S, Shinohara, H and Tamura, Y: Comparisons of short- and intermediate-term effects of pitavastatin versus atorvastatin on lipid profiles, fibrinolytic parameter, and endothelial function. Int J Cardiol, 2008; 125: 136-138","DOI":"10.1016\/j.ijcard.2007.01.040"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Sasaki, J, Ikeda, Y, Kuribayashi, T, Kajiwara, K, Biro, S, Yamamoto, K, Ageta, M, Kobori, S, Saikawa, T, Otonari, T and Kono, S: A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance. Clin Ther, 2008; 30: 1089-1101","DOI":"10.1016\/j.clinthera.2008.05.017"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Moroi, M, Nagayama, D, Hara, F, Saiki, A, Shimizu, K, Takahashi, M, Sato, N, Shiba, T, Sugimoto, H, Fujioka, T, Chiba, T, Nishizawa, K, Usui, S, Iwasaki, Y, Tatsuno, I, Sugi, K, Yamasaki, J, Yamamura, S and Shirai, K: Outcome of pitavastatin versus atorvastatin therapy in patients with hypercholesterolemia at high risk for atherosclerotic cardiovascular disease. Int J Cardiol, 2020; 305: 139-146","DOI":"10.1016\/j.ijcard.2020.01.006"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Kawano, M, Nagasaka, S, Yagyu, H and Ishibashi, S: Pitavastatin decreases plasma prebeta1-HDL concentration and might promote its disappearance rate in hypercholesterolemic patients. J Atheroscler Thromb, 2008; 15: 41-46","DOI":"10.5551\/jat.E532"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Miyamoto-Sasaki, M, Yasuda, T, Monguchi, T, Nakajima, H, Mori, K, Toh, R, Ishida, T and Hirata, K: Pitavastatin increases HDL particles functionally preserved with cholesterol efflux capacity and antioxidative actions in dyslipidemic patients. J Atheroscler Thromb, 2013; 20: 708-716","DOI":"10.5551\/jat.17210"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/1\/29_59881\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T04:09:51Z","timestamp":1641010191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/1\/29_59881\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.59881","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,1]]},"article-number":"59881"}}